Low-molecular-weight heparin for venous thromboprophylaxis in ambulatory cancer patients: A meta-analysis Nicole M. Kuderer, Alok A. Khorana, Charles W. Francis et al Duke University, Durham, NC; University of Rochester, Rochester, NY
{"Image DocumentName": "Low-molecular-weight heparin for venous thromboprophylaxis in ambulatory cancer patients: A meta-analysis Nicole M. Kuderer, Alok A. Khorana, Charles W. Francis et al Duke University, Durham, NC; University of Rochester, Rochester, NY", "Image ImageDescription": "Literature Search: Medline, EMBASE, Cochrane Library, Conference Proceedings, Hand Searching of References. Major Inclusion Criteria: RCT of LMWH VTE prophylaxis in adult ambulatory cancer patients. Treatment Group: LMWH. Control Group: placebo or no Rx. Major Exclusion Criteria: Non-cancer patients. Non-randomized trials. Surgery, Catheter trials, or intraportal heparin infusion. Combination of anticoagulants.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}